Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Br J Cancer ; 124(8): 1357-1360, 2021 04.
Article in English | MEDLINE | ID: covidwho-1072146


The COVID-19 pandemic has had an unprecedented impact on the National Health Service in United Kingdom. The UK Ocular Oncology Services evaluated the impact on the adult eye cancer care in the UK. All four adult Ocular Oncology centres participated in a multicentre retrospective review comparing uveal melanoma referral patterns and treatments in a 4-month period during the national lockdown and first wave of the COVID-19 pandemic in 2020 with corresponding periods in previous 2 years. During the national lockdown, referral numbers and confirmed uveal melanoma cases reduced considerably, equalling to ~120 fewer diagnosed uveal melanoma cases compared to previous 2 years. Contrary to the recent trend, increased caseloads of enucleation and stereotactic radiosurgery (p > 0.05), in comparison to fewer proton beam therapy (p < 0.05), were performed. In the 4-month period following lockdown, there was a surge in clinical activities with more advanced diseases (p < 0.05) presenting to the services. As the COVID-19 pandemic continues to mount pressure and reveal its hidden impact on the eye cancer care, it is imperative for the Ocular Oncology Services to plan recovery strategies and innovative ways of working.

COVID-19/epidemiology , Eye Neoplasms/epidemiology , Melanoma/epidemiology , Pandemics , Uveal Neoplasms/epidemiology , COVID-19/complications , COVID-19/therapy , COVID-19/virology , Communicable Disease Control/methods , Eye Neoplasms/complications , Eye Neoplasms/therapy , Eye Neoplasms/virology , Humans , Melanoma/complications , Melanoma/therapy , Melanoma/virology , Proton Therapy/methods , SARS-CoV-2/pathogenicity , State Medicine , United Kingdom/epidemiology , Uveal Neoplasms/complications , Uveal Neoplasms/therapy , Uveal Neoplasms/virology
Klin Monbl Augenheilkd ; 237(12): 1400-1408, 2020 Dec.
Article in English, German | MEDLINE | ID: covidwho-962241


The customary doctor and patient interactions are currently undergoing significant changes through technological advances in imaging and data processing and the need for reducing person-to person contacts during the COVID-19 crisis. There is a trend away from face-to-face examinations to virtual assessments and decision making. Ophthalmology is particularly amenable to such changes, as a high proportion of clinical decisions are based on routine tests and imaging results, which can be assessed remotely. The uptake of digital ophthalmology varies significantly between countries. Due to financial constraints within the National Health Service, specialized ophthalmology units in the UK have been early adopters of digital technology. For more than a decade, patients have been managed remotely in the diabetic retinopathy screening service and virtual glaucoma clinics. We describe the day-to-day running of such services and the doctor and patient experiences with digital ophthalmology in daily practice.

COVID-19 , Diabetes Mellitus , Diabetic Retinopathy , Glaucoma , Ophthalmology , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/epidemiology , Diabetic Retinopathy/therapy , Glaucoma/diagnosis , Glaucoma/therapy , Humans , Mass Screening , Pandemics , SARS-CoV-2 , State Medicine , United Kingdom